pLC-ZsGreen-P2A-Blast Citations (1)
Originally described in: CK1alpha and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma.Patil A, Manzano M, Gottwein E Blood. 2018 Aug 9;132(6):577-586. doi: 10.1182/blood-2018-01-828418. Epub 2018 Jun 28. PubMed Journal
Articles Citing pLC-ZsGreen-P2A-Blast
| Articles |
|---|
| Immunosuppression by Mutated Calreticulin Released from Malignant Cells. Liu P, Zhao L, Loos F, Marty C, Xie W, Martins I, Lachkar S, Qu B, Waeckel-Enee E, Plo I, Vainchenker W, Perez F, Rodriguez D, Lopez-Otin C, van Endert P, Zitvogel L, Kepp O, Kroemer G. Mol Cell. 2019 Nov 23. pii: S1097-2765(19)30833-0. doi: 10.1016/j.molcel.2019.11.004. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.